Stay updated on Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5. This indicates a minor update to the entry's metadata rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-08T20:34:26.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, reflecting a small editorial update to the page metadata.
    Difference
    0.1%
    Check dated 2026-07-25T13:19:31.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page’s revision tag was updated to v3.6.3, replacing the previous v3.6.2, indicating a newer version of the page.
    Difference
    0.1%
    Check dated 2026-07-04T04:16:59.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.0 to v3.6.2. This indicates a newer version of the page was published.
    Difference
    0.1%
    Check dated 2026-06-27T02:24:31.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The Study Details page now displays a 'No longer looking for participants' notice and adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a new Revision: v3.6.0 entry. The 'Intervention/Treatment' heading and the earlier 'Revision: v3.5.5' entry have been removed.
    Difference
    0.5%
    Check dated 2026-06-12T14:49:43.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The study record’s revision label was updated to v3.5.5, reflecting an editorial update to the page. The previous revision label v3.5.4 was replaced.
    Difference
    0.1%
    Check dated 2026-06-05T11:26:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.